-The Hindu This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. The SDGs will help countries frame their policies and strategies towards achieving these mutually agreed upon goals and targets. SDG 3, which aims to ensure good...

-Frontline   Swagata Raha, a senior legal researcher (Consultant) at the Centre for Child and the Law, National Law School of India University, Bengaluru, said the Juvenile Justice Bill, 2015, “incorrectly assumes that children are competent to stand trial as adults”. Currently pursuing Master of Studies in International Human Rights Law at the University of Oxford, Swagata Raha worked extensively on the campaign against the Juvenile Justice Bill and has written extensively...

-The Indian Express When the UPA government passed the Protection of Children from Sexual Offences Act, 2012, that laid down in clear terms that the age of consent for sex is 18 years, even then activists had warned against such misuse. THE Supreme Court refused to extend the detention of the juvenile convicted in the 2012 Delhi gangrape saying it has to go by the law as it stands today. Lawmakers...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...